• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富血小板纤维蛋白、引导组织再生和开放式清创术治疗骨内缺损:一项随机对照试验。

INTRABONY DEFECT TREATMENT WITH PLATELET-RICH FIBRIN, GUIDED TISSUE REGENERATION AND OPEN-FLAP DEBRIDEMENT: A RANDOMIZED CONTROLLED TRIAL.

机构信息

Division of Odonto-Stomatology, School of Medicine, Ho Chi Minh City, Vietnam; Vietnam National University, Ho Chi Minh City, Vietnam.

出版信息

J Evid Based Dent Pract. 2021 Sep;21(3):101545. doi: 10.1016/j.jebdp.2021.101545. Epub 2021 Mar 19.

DOI:10.1016/j.jebdp.2021.101545
PMID:34479673
Abstract

OBJECTIVE

To comparatively assess the outcomes of the treatment of periodontal intrabony defects with platelet-rich fibrin (PRF) combined with open-flap debridement (OFD), guided tissue regeneration (GTR) or OFD alone based on clinical, radiographic, and wound healing parameters for 12 months of follow-up.

MATERIALS AND METHODS

Ninety intrabony defects were randomly divided into 3 different groups and treated as group 1 (PRF + OFD), group 2 (GTR), or group 3 (OFD alone). Clinical parameters, including the plaque index, gingival index, bleeding on probing, probing depth (PD), clinical attachment loss (CAL), and tooth mobility were assessed at 3, 6, and 12 months. Additionally, the wound healing index was assessed at 7 and 14 days postsurgery. Radiographic parameters, including bony defect fill and alveolar crestal resorption, were measured at 6 and 12 months postsurgery and calculated using image analysis software.

RESULTS

Intragroup comparisons showed consistently significant improvements in all the clinical and radiographic parameters in the 3 groups at 12 months postsurgery. Compared to baseline, in group 1, the PD decreased to 2.37 ± 0.56; 3.30 ± 0.84; 4.80 ± 0.71 mm, and CAL decreased to 2.23 ± 0.90; 3.33 ± 0.71; 5.00 ± 0.46 mm; in group 2, the PD decreased to 2.30 ± 0.60; 3.23 ± 0.86; 4.63 ± 0.67 mm, and CAL decreased to 2.00 ± 0.98; 3.20 ± 0.71; 4.53 ± 0.57 mm); and in group 3, the PD decreased to 1.87 ± 0.68; 2.57 ± 1.36; 3.37 ± 1.00 mm, and CAL decreased to 1.60 ± 0.93; 2.23 ± 1.22; 3.37 ± 1.22 mm at 3, 6, and 12 months postsurgery, respectively. The bone fill percentages in group 1 (26.45 ± 16.47 and 45.25 ± 5.20%), group 2 (22.20 ± 15.76 and 42.15 ± 6.39%) and group 3 (10.21 ± 6.47 and 23.13 ± 6.98%) were observed at 6 and 12 months postsurgery. The alveolar crestal resorption levels were -1.07 ± 0.52 and -1.70 ± 0.60 mm in group 1, -1.03 ± 0.72 and -1.47 ± 0.73 mm in group 2 and 0.37 ± 0.62 and 0.43 ± 0.73 mm in group 3, respectively. The percentages of sites with a WHI score of 1 were 93% and 100% in group 1, 81%, and 94% in group 2 and 45% and 71% in group 3 at 7 and 14 days postsurgery, respectively.

CONCLUSIONS

Compared to GTR, PRF yielded comparable treatment outcomes and periodontal tissue healing in terms of improvements in clinical and radiographic parameters. Compared to OFD alone, PRF also significantly improved these parameters in the treatment of intrabony defects.

摘要

目的

通过临床、影像学和伤口愈合参数,比较评估富血小板纤维蛋白(PRF)联合翻开瓣清创术(OFD)、引导组织再生术(GTR)或 OFD 单独治疗牙周骨内缺损 12 个月的治疗效果。

材料和方法

90 个骨内缺损随机分为 3 组,分别为第 1 组(PRF+OFD)、第 2 组(GTR)和第 3 组(OFD 单独治疗)。分别于术后 3、6 和 12 个月评估菌斑指数、牙龈指数、探诊出血、探诊深度(PD)、临床附着丧失(CAL)和牙齿松动度等临床参数。此外,还在术后 7 和 14 天评估伤口愈合指数。术后 6 和 12 个月,使用图像分析软件测量影像学参数,包括骨缺损填充和牙槽嵴吸收。

结果

组内比较显示,3 组在术后 12 个月的所有临床和影像学参数均有持续显著改善。与基线相比,第 1 组 PD 降低至 2.37±0.56、3.30±0.84、4.80±0.71mm,CAL 降低至 2.23±0.90、3.33±0.71、5.00±0.46mm;第 2 组 PD 降低至 2.30±0.60、3.23±0.86、4.63±0.67mm,CAL 降低至 2.00±0.98、3.20±0.71、4.53±0.57mm;第 3 组 PD 降低至 1.87±0.68、2.57±1.36、3.37±1.00mm,CAL 降低至 1.60±0.93、2.23±1.22、3.37±1.22mm,分别在术后 3、6 和 12 个月。第 1 组(26.45±16.47%和 45.25±5.20%)、第 2 组(22.20±15.76%和 42.15±6.39%)和第 3 组(10.21±6.47%和 23.13±6.98%)的骨填充百分比在术后 6 和 12 个月时观察到。第 1 组牙槽嵴吸收水平为-1.07±0.52 和-1.70±0.60mm,第 2 组为-1.03±0.72 和-1.47±0.73mm,第 3 组为 0.37±0.62 和 0.43±0.73mm,分别在术后 7 和 14 天。第 1 组的 WHI 评分在第 7 和 14 天分别为 93%和 100%,第 2 组为 81%和 94%,第 3 组为 45%和 71%。

结论

与 GTR 相比,PRF 在改善临床和影像学参数方面取得了与 GTR 相当的治疗效果和牙周组织愈合效果。与 OFD 单独治疗相比,PRF 也显著改善了这些参数在骨内缺损的治疗效果。

相似文献

1
INTRABONY DEFECT TREATMENT WITH PLATELET-RICH FIBRIN, GUIDED TISSUE REGENERATION AND OPEN-FLAP DEBRIDEMENT: A RANDOMIZED CONTROLLED TRIAL.富血小板纤维蛋白、引导组织再生和开放式清创术治疗骨内缺损:一项随机对照试验。
J Evid Based Dent Pract. 2021 Sep;21(3):101545. doi: 10.1016/j.jebdp.2021.101545. Epub 2021 Mar 19.
2
Platelet-rich fibrin with 1% metformin for the treatment of intrabony defects in chronic periodontitis: a randomized controlled clinical trial.富含血小板纤维蛋白联合1%二甲双胍治疗慢性牙周炎骨内缺损:一项随机对照临床试验
J Periodontol. 2015 Jun;86(6):729-37. doi: 10.1902/jop.2015.140646. Epub 2015 Mar 12.
3
Use of platelet-rich fibrin for the treatment of periodontal intrabony defects: a systematic review and meta-analysis.富血小板纤维蛋白用于治疗牙周骨内缺损:一项系统评价和荟萃分析。
Clin Oral Investig. 2021 May;25(5):2461-2478. doi: 10.1007/s00784-021-03825-8. Epub 2021 Feb 20.
4
Evaluation of platelet-rich fibrin in the treatment of decorticated intrabony defects: a randomized clinical trial.富血小板纤维蛋白在去皮质骨内骨缺损治疗中的评价:一项随机临床试验。
Quintessence Int. 2023 Nov 28;54(10):808-820. doi: 10.3290/j.qi.b4325359.
5
Platelet-Rich Fibrin Combined With a Porous Hydroxyapatite Graft for the Treatment of 3-Wall Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial.富血小板纤维蛋白联合多孔羟基磷灰石移植物治疗慢性牙周炎三壁骨内缺损的随机对照临床试验。
J Periodontol. 2017 Dec;88(12):1288-1296. doi: 10.1902/jop.2012.110722.
6
A novel marginal periosteal pedicle graft as an autogenous guided tissue membrane for the treatment of intrabony periodontal defects.一种新型边缘骨膜蒂移植物作为自体引导组织膜用于治疗骨内牙周缺损。
J Int Acad Periodontol. 2008 Oct;10(4):106-17.
7
Clinical and radiographic evaluation of low-speed platelet-rich fibrin (PRF) for the treatment of intra-osseous defects of stage-III periodontitis patients: a randomized controlled clinical trial.临床和影像学评估低速富血小板纤维蛋白(PRF)治疗 III 期牙周炎患者的骨内缺损:一项随机对照临床试验。
Clin Oral Investig. 2022 Nov;26(11):6671-6680. doi: 10.1007/s00784-022-04627-2. Epub 2022 Jul 25.
8
Platelet-Rich Fibrin in Regeneration of Intrabony Defects: A Randomized Controlled Trial.富血小板纤维蛋白在骨内缺损再生中的作用:一项随机对照试验。
J Periodontol. 2017 Nov;88(11):1192-1199. doi: 10.1902/jop.2017.130710. Epub 2017 Aug 18.
9
Comparison of GTR, T-PRF and open-flap debridement in the treatment of intrabony defects with endo-perio lesions: a randomized controlled trial.引导组织再生术(GTR)、浓缩生长因子(T-PRF)与敞开式翻瓣清创术治疗牙周牙髓联合病变骨内缺损的随机对照研究。
Med Oral Patol Oral Cir Bucal. 2020 Jan 1;25(1):e117-e123. doi: 10.4317/medoral.23231.
10
Clinical and radiographic evaluation of 0.8% hyaluronic acid as an adjunct to open flap debridement in the treatment of periodontal intrabony defects: randomized controlled clinical trial.0.8%透明质酸作为辅助手段联合开放式清创术治疗牙周内骨缺损的临床和影像学评价:随机对照临床试验。
Clin Oral Investig. 2021 Sep;25(9):5257-5271. doi: 10.1007/s00784-021-03834-7. Epub 2021 Feb 17.

引用本文的文献

1
A comparative study of platelet-rich fibrin plugs versus biphasic calcium phosphate in treating infrabony defects in patients with periodontitis: Insights from a randomized controlled trial.富血小板纤维蛋白凝块与双相磷酸钙治疗牙周炎患者骨下袋缺损的对比研究:一项随机对照试验的见解
J Clin Exp Dent. 2025 May 1;17(5):e560-e568. doi: 10.4317/jced.62666. eCollection 2025 May.
2
Applications of Platelet-Rich Fibrin (PRF) Membranes Alone or in Combination with Biomimetic Materials in Oral Regeneration: A Narrative Review.富血小板纤维蛋白(PRF)膜单独或与仿生材料联合应用于口腔再生的叙述性综述
Biomimetics (Basel). 2025 Mar 11;10(3):172. doi: 10.3390/biomimetics10030172.
3
Influence of alloplastic materials, biologics, and their combinations, along with defect characteristics, on short-term intrabony defect surgical treatment outcomes: a systematic review and network meta-analysis.
异体材料、生物制品及其组合,以及骨内缺损特征对骨内缺损短期手术治疗效果的影响:一项系统评价和网状Meta分析
BMC Oral Health. 2025 Mar 20;25(1):413. doi: 10.1186/s12903-025-05782-0.
4
Autogenous platelet concentrates for treatment of intrabony defects-A systematic review with meta-analysis.自体血小板浓缩物治疗骨内缺损——一项荟萃分析的系统评价
Periodontol 2000. 2025 Feb;97(1):153-190. doi: 10.1111/prd.12598. Epub 2024 Oct 19.
5
Periodontal regeneration using platelet-rich fibrin. Furcation defects: A systematic review with meta-analysis.使用富血小板纤维蛋白进行牙周组织再生。根分叉病变:一项系统评价与荟萃分析
Periodontol 2000. 2025 Feb;97(1):191-214. doi: 10.1111/prd.12583. Epub 2024 Sep 26.
6
Regeneration of periodontal intrabony defects using platelet-rich fibrin (PRF): a systematic review and network meta-analysis.使用富含血小板纤维蛋白(PRF)再生牙周骨内缺损:系统评价和网络荟萃分析。
Odontology. 2024 Oct;112(4):1047-1068. doi: 10.1007/s10266-024-00949-7. Epub 2024 May 21.
7
From Basic Science to Clinical Practice: A Review of Current Periodontal/Mucogingival Regenerative Biomaterials.从基础科学到临床实践:当前牙周/黏骨膜再生生物材料的综述。
Adv Sci (Weinh). 2024 May;11(17):e2308848. doi: 10.1002/advs.202308848. Epub 2024 Feb 21.
8
The use of integrin binding domain loaded hydrogel (RGD) with minimally invasive surgical technique in treatment of periodontal intrabony defect: a randomized clinical and biochemical study.整合素结合域载药水凝胶(RGD)联合微创外科技术治疗牙周骨内缺损的随机临床及生化研究。
J Appl Oral Sci. 2023 Dec 22;31:e20230263. doi: 10.1590/1678-7757-2023-0263. eCollection 2023.
9
Platelet-Rich Fibrin in Oral Surgery and Implantology: A Narrative Review.富血小板纤维蛋白在口腔外科和种植牙学中的应用:一篇叙述性综述
Transfus Med Hemother. 2022 Dec 22;50(4):348-359. doi: 10.1159/000527526. eCollection 2023 Aug.
10
Comparing efficacies of autologous platelet concentrate preparations as mono-therapeutic agents in intra-bony defects through systematic review and meta-analysis.通过系统评价和荟萃分析比较自体血小板浓缩制剂作为单一治疗剂治疗骨内缺损的疗效。
J Oral Biol Craniofac Res. 2023 Nov-Dec;13(6):671-681. doi: 10.1016/j.jobcr.2023.08.007. Epub 2023 Sep 6.